Clinical Trials on Electrophilic Fatty Acids in New Zealand
Total 401 results
-
Arrowhead PharmaceuticalsCompletedNon-alcoholic SteatohepatitisNew Zealand
-
Ultragenyx Pharmaceutical IncCompletedLong-chain Fatty Acid Oxidation Disorders (LC-FAOD)United States
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH) | Primary Sclerosing Cholangitis (PSC)United States, New Zealand
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH) | Nonalcoholic Fatty Liver Disease (NAFLD)United States, New Zealand
-
Arcturus Therapeutics, Inc.CompletedOrnithine Transcarbamylase DeficiencyNew Zealand
-
Ultragenyx Pharmaceutical IncRecruitingLong-chain Fatty Acid Oxidation Disorders (LC-FAOD)United States, Canada
-
Baxter Healthcare CorporationCompletedEssential Fatty Acid Deficiency (EFAD)United States
-
Columbia UniversityGlaxoSmithKlineCompletedNon-Alcoholic Fatty Liver DiseaseUnited States
-
Northwell HealthCompletedNon-Alcoholic Fatty Liver DiseaseUnited States
-
Novartis PharmaceuticalsTerminatedNon-alcoholic Steatohepatitis NASHUnited Kingdom, United States, Australia, New Zealand, Switzerland, Jordan, Georgia, Puerto Rico
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH)Canada, United States, Hong Kong, United Kingdom, Switzerland, New Zealand
-
GenMont Biotech IncorporationFu Jen Catholic University HospitalRecruitingNon-Alcoholic Fatty Liver DiseaseTaiwan
-
Weill Medical College of Cornell UniversityRecruitingNon-Alcoholic Fatty Liver DiseaseUnited States
-
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical...RecruitingMetabolic Associated Fatty Liver DiseaseTaiwan
-
Fu Jen Catholic University HospitalEnrolling by invitationNon-alcoholic Fatty Liver DiseaseTaiwan
-
Enanta Pharmaceuticals, IncICON Clinical Research; Triangle BiostatisticsCompletedNon-Alcoholic SteatohepatitisUnited States, United Kingdom, New Zealand, Canada, France, Puerto Rico
-
Institute of Liver and Biliary Sciences, IndiaNot yet recruiting
-
Rockefeller UniversityNational Institutes of Health (NIH); Weill Medical College of Cornell UniversityCompletedObesity | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Icahn School of Medicine at Mount SinaiCompletedNonalcoholic Fatty Liver DiseaseUnited States
-
Institute of Liver and Biliary Sciences, IndiaUnknownNon-Alcoholic Fatty Liver DiseaseIndia
-
PfizerCompletedNon-alcoholic Fatty Liver DiseaseUnited States
-
Dartmouth-Hitchcock Medical CenterCompletedHepatic Steatosis | Nonalcoholic Fatty Liver Disease | SteatohepatitisUnited States
-
Yale UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
PfizerCompleted
-
Institute of Liver and Biliary Sciences, IndiaWithdrawnNon Alcoholic SteatohepatitisIndia
-
PfizerCompletedLiver Fibrosis | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Northwell HealthWithdrawnNon-alcoholic Fatty Liver Disease (NAFLD)United States
-
Institute of Liver and Biliary Sciences, IndiaRecruitingMetabolic Syndrome | Non-Alcoholic Fatty Liver DiseaseIndia
-
Icahn School of Medicine at Mount SinaiNational Institutes of Health (NIH)CompletedNASH - Nonalcoholic Steatohepatitis | Steatosis of LiverUnited States
-
Institute of Liver and Biliary Sciences, IndiaCompletedNon-alcoholic SteatohepatitisIndia
-
National Institute of Diabetes and Digestive and...Johns Hopkins UniversityTerminatedNAFLD - Nonalcoholic Fatty Liver DiseaseUnited States
-
National Institute of Diabetes and Digestive and...National Cancer Institute (NCI); National Center for Advancing Translational... and other collaboratorsCompletedNonalcoholic Fatty Liver Disease (NAFLD)United States
-
Institute of Liver and Biliary Sciences, IndiaWithdrawnNon Alcoholic SteatohepatitisIndia
-
Enyo PharmaCompletedHealthy | NASH - Nonalcoholic SteatohepatitisAustralia
-
Weill Medical College of Cornell UniversityYMCAActive, not recruitingLiver Diseases | Weight Loss | NAFLDUnited States
-
Institute of Liver and Biliary Sciences, IndiaCompletedNon Alcoholic SteatohepatitisIndia
-
Northwell HealthTerminatedNon-Alcoholic Fatty Liver Disease | Probiotics MeSH Descriptor Data 2018 | Interleukin-17 MeSH Descriptor Data 2018United States
-
Merck Sharp & Dohme LLCCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Argentina, Australia, Canada, France, Israel, Italy, Korea, Republic of, Mexico, New Zealand, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
-
Institute of Liver and Biliary Sciences, IndiaUnknownNon Alcoholic SteatohepatitisIndia
-
GenfitTerminatedNon Alcoholic SteatohepatitisUnited States
-
Meridian Bioscience, Inc.CompletedNon-Alcoholic SteatohepatitisUnited States, France, Belgium, United Kingdom
-
PfizerCompletedNon-alcoholic Fatty Liver Disease | Non-alcoholic SteatohepatitisUnited States
-
Hepanova Inc.UnknownNon-Alcoholic Steatohepatitis (NASH)United States
-
Far Eastern Memorial HospitalMinistry of Science and Technology, TaiwanRecruiting
-
Poxel SACompletedNonalcoholic Fatty LiverUnited States
-
Yale UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Recruiting
-
Target PharmaSolutions, Inc.RecruitingNonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverUnited States, Germany, Spain
-
89bio, Inc.ProSciento, Inc.Completed
-
Columbia UniversityUniversity of California, BerkeleyRecruitingInsulin Resistance | Prediabetic State | Hyperinsulinemia | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Yale UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedHypertriglyceridemia | Steatohepatitis | Non Alcoholic Fatty Liver Disease | Alanine Aminotransferase, Plasma Level of, Quantitative Trait Locus 1United States